The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer
Clinical trial NCT05802394 · RECRUITING
Trial details
- NCT number
- NCT05802394
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2026-02-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.